REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad de Citologia y Patologia I.P.S. S. A. S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Unidad de Citologia y Patologia I.P.S. S. A. S. Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad de Citologia y Patologia I.P.S. S. A. S. is based in Colombia. The head office is in Medellin. The enterprise operates in the Diagnostic Imaging Centers industry. The company was established on February 28, 2012. It currently has a total number of 10 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 21.52% in 2023. Its total assets decreased by 14.13% over the same period. The net profit margin of Unidad de Citologia y Patologia I.P.S. S. A. S. decreased by 5.36% in 2023.

Headquarters
Calle 2 Sur 46 55 Cons. 330 Fase I
Medellin; Antioquia;

Contact Details: Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.

Basic Information
Total Employees:
Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.
Outstanding Shares:
Purchase the Unidad de Citologia y Patologia I.P.S. S. A. S. report to view the information.
Incorporation Date:
February 28, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad de Citologia y Patologia I.P.S. S. A. S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
21.52%
Total operating revenue
21.52%
Operating profit (EBIT)
-10.56%
EBITDA
-4.23%
Net Profit (Loss) for the Period
-83.81%
Total assets
-14.13%
Total equity
4.47%
Operating Profit Margin (ROS)
-3.3%
Net Profit Margin
-5.36%
Return on Equity (ROE)
-4.17%
Quick Ratio
5.56%
Cash Ratio
1.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?